Shiga toxin/verocytotoxin-producing escherichia coli infections: Practical Clinical Perspectives

T. Keefe Davis, Nicole C.A.J. Van De Kar, Phillip I. Tarr

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Escherichia coli strains that produce Shiga toxins/verotoxins are rare, but important, causes of human disease. They are responsible for a spectrum of illnesses that range from the asymptomatic to the life-threatening hemolyticuremic syndrome; diseases caused by E. coli belonging to serotype O157:H7 are exceptionally severe. Each illness has a fairly predictable trajectory, and good clinical practice at one phase can be inappropriate at other phases. Early recognition, rapid and definitive microbiology, and strategic selection of tests increase the likelihood of good outcomes. The best management of these infections consists of avoiding antibiotics, antimotility agents, and narcotics and implementing aggressive intravenous volume expansion, especially in the early phases of illness.

Original languageEnglish
Article numberEHEC-0025-2014
JournalMicrobiology spectrum
Volume2
Issue number4
DOIs
StatePublished - 2014

Fingerprint Dive into the research topics of 'Shiga toxin/verocytotoxin-producing escherichia coli infections: Practical Clinical Perspectives'. Together they form a unique fingerprint.

Cite this